BioStem CEO, Jason Matuszewski, will present on Wednesday, May 1, 2024, at 11.30 am PST POMPANO BEACH, FLORIDA, April 25, 2024—BioStem Technologies Inc. (OTC: BSEM),
New commitment valued at $300,000 brings total annualized value to over $8M BranchOut Food’s dried fruit products expected to enter 1,400 stores in September 2024
Strategic Audit Completion Set to Enhance BioStem Technologies’ Market Position and Shareholder Value POMPANO BEACH, FLORIDA, April 24, 2024—BioStem Technologies Inc. (OTC: BSEM), a leading
Registration Statement on Form S-4 Declared Effective by the Securities and Exchange Commission Special Meeting of SensaSure and Verde Stockholders to be held on May
Rodedawg enters into 11 Billion dollar topical pain relief market COSTA MESA, CA, April 23, 2024 - Rodedawg International Industries, Inc. (OTC: RWGI) is pleased
Significant milestones achieved for SSi Mantra Made-in-India surgical robotic system FORT LAUDERDALE, FL, April 22, 2024 – SS Innovations International, Inc. (the “Company” or “SS
SAN FRANCISCO, CA, April 12, 2024 – American Shared Hospital Services (NYSE American: AMS) (the “Company”), a leading provider of turnkey technology solutions for stereotactic
IRVINE, CA, April 11, 2024 – Oncocyte Corporation (NASDAQ: OCX), (“Oncocyte” or the “Company”), a precision diagnostics company, today announced that it has entered into
Conference Call on Friday, April 12, 2024 at 5:00 a.m. PT / 8:00 a.m. ET IRVINE, CA, April 12, 2024 – Oncocyte Corporation (Nasdaq: OCX), a
– Bio-Rad expects to make equity investment in support of deal – Agreement provides for global exclusivity in transplant monitoring commercialization – Bio-Rad granted subsequent
PRISM MediaWire
info@prismmediawire.com
Phone: 646-780-8850
